drugset / Trial / NCT01473472

On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men

NCT01473472

Phase 3 Completed 400 enrolled ANRS, Emerging Infectious Diseases
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This phase III, multi-centre, comparative, double-blind, randomized trial on 2 parallel groups is designed to evaluate a strategy for the prevention of HIV infection including "on demand" antiretroviral pre-exposure with Truvada versus placebo, associated with overall prevention (counselling, condoms, sexually transmitted diseases (STD) screening, hepatitis B virus (HBV) and hepatitis A virus (HAV) vaccinations and post-exposure treatment of HIV infection) in men who have sex with men (MSM), exposed to the risk of HIV infection. Indeed recent studies have reported a higher incidence of new HIV infection in MSM as compared to the general population, new approaches to the prevention of HIV infection are, therefore, necessary in order to consider the limits of current strategies.

Timeline

Start
2012-01
Primary completion
2016-06-30
Completion
2016-12-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tenofovir disoproxil fumarate Small molecule 300 mg Oral
Comparator emtricitabine Other / unclassified 200 mg Oral